Doing Clinton a favor

Doing Clinton a favor

The industry's "SWAT" team of biotechnology executives made its first visit to Capitol Hill last week while pharmaceutical companies advanced, and sometimes argued over, proposals for restraining drug price increases. Biotechnology company representatives quietly visited members of Congress while the pitch of the debate